TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 39 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $152,000 | -42.9% | 74,331 | -24.5% | 0.00% | – |
| Q2 2018 | $266,000 | +216.7% | 98,464 | +168.6% | 0.00% | – |
| Q1 2018 | $84,000 | -4.5% | 36,664 | +39.9% | 0.00% | – |
| Q4 2017 | $88,000 | +137.8% | 26,201 | +122.2% | 0.00% | – |
| Q3 2017 | $37,000 | -90.1% | 11,791 | -55.5% | 0.00% | -100.0% |
| Q1 2015 | $372,000 | – | 26,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $26,531,000 | 1.20% |
| WALL STREET ASSOCIATES | 250,000 | $3,510,000 | 0.33% |
| QVT Financial LP | 368,330 | $5,001,000 | 0.28% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $6,809,000 | 0.22% |
| Perceptive Advisors | 100,000 | $1,404,000 | 0.11% |
| Visium Asset Management, LP | 461,336 | $6,477,000 | 0.10% |
| Opaleye Management Inc. | 12,172 | $171,000 | 0.08% |
| Candriam S.C.A. | 125,000 | $1,755,000 | 0.04% |
| Spark Investment Management LLC | 13,300 | $186,000 | 0.03% |
| Nicholas Investment Partners, LP | 30,000 | $421,000 | 0.03% |